Labs / Assays & in vitro testing
EpiVax
Providence, RI, United States · epivax.com
GMP
EpiVax provides immunogenicity assessment services for biologic and vaccine developers. It combines in silico analysis, in vitro assays, and consulting to support programs from early discovery through regulatory submission. The company is based in Providence, Rhode Island, USA.
Their website has a general contact form; we send your quote request through it.
What they offer
ISPRI™ Downselect™
In silico service that helps identify candidates with the lowest immunogenic risk early in development.
ISPRI™ Quantify™
In silico service for assessing overall and regional immunogenic and tolerogenic potential in therapeutic sequences.
ISPRI™ Analyze™
In silico service for therapeutic immunogenicity analysis within the ISPRI toolkit.
ISPRI™ Evaluate™
In silico service for therapeutic immunogenicity evaluation within the ISPRI toolkit.
ISPRI-HCP™
In silico service focused on immunogenicity-related analysis within the ISPRI toolkit.
ISPRI™ Design™
In silico service for optimizing protein regions and supporting peptide design for testing.
PANDA® Screening
In silico screening service related to immunogenicity assessment.
iVAX™
Web-based computational vaccine design toolkit for epitope mapping, antigen selection, immunogen design, and vaccine efficacy prediction.
EpiCC™
Fee-for-service vaccine analysis offered as part of the vaccine in silico services.
PreVAX™
Fee-for-service vaccine analysis offered as part of the vaccine in silico services.
All In Vitro Assays
Experimental in vitro assays used to validate in silico predictions and assess immunogenicity factors.
Class II HLA Binding Assay
Cell-free in vitro assay that measures relative binding affinity of putative HLA ligands using recombinant Class II HLA-DR supertype alleles.
Generic Peptide PANDA® Assays
Assays for assessing immunogenic potential of generic peptide APIs and associated impurities.
Trusted Expert Advice (TEA)
Consulting service providing expert immunogenicity advice across development programs.
IRA / ISI Regulatory Writing Support
Regulatory writing support for immunogenicity risk assessment and integrated summaries.
What they work on
- Modalities
- Small molecule, Antibody, ADC, Peptide, Vaccine
- Species and models
- humans, livestock
- Assays and studies
- cell-free in vitro assay, competition-based assay, HLA binding assay, in vitro validation assay, immunogenicity assessment, T cell epitope mapping, epitope density analysis
- Instruments and platforms
- BLAST
- Scale and capacity
- 13M+ sequences analyzed
- Therapeutic areas
- immunogenicity assessment, therapeutic development, vaccine design, regulatory strategy, biologics, antibody-drug conjugates, infectious disease, cancer
- Type
- CRO
- Sites
- Providence, USA
- Serves
- USA
- Address
- 188 Valley Street, Suite 424 Providence, RI 02909, USA
Similar labs. Bioneeds, Aurigene Pharmaceutical Services, Axela Biosciences, Inc, Biofidus GmbH
Found in a contract services directory. Listing built from epivax.com. Work here? Claim this listing.